OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE Drug Patent Profile

Which patents cover Olmesartan Medoxomil And Hydrochlorothiazide, and when can generic versions of Olmesartan Medoxomil And Hydrochlorothiazide launch?

Olmesartan Medoxomil And Hydrochlorothiazide is a drug marketed by Accord Hlthcare, Alembic, Aurobindo Pharma, Macleods Pharms Ltd, Natco Pharma Usa, Prinston Inc, Teva Pharms Usa, Torrent, Umedica, and Zydus Pharms. and is included in ten NDAs.

The generic ingredient in OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; olmesartan medoxomil. There are thirty-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; olmesartan medoxomil profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Olmesartan Medoxomil And Hydrochlorothiazide

A generic version of OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE was approved as hydrochlorothiazide; olmesartan medoxomil by ALKEM LABS LTD on July 11^th, 2024.

Summary for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

US Patents:	0
Applicants:	10
NDAs:	10
Finished Product Suppliers / Packagers:	10
Clinical Trials:	26
What excipients (inactive ingredients) are in OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE?	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE excipients list
DailyMed Link:	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE at DailyMed

Recent Clinical Trials for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Pharmtechnology LLC	Phase 1
Altasciences Company, Inc.	Phase 1
Altasciences Company Inc.	Phase 1

See all OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

Drug Class	Angiotensin 2 Receptor Blocker Thiazide Diuretic
Mechanism of Action	Angiotensin 2 Receptor Antagonists
Physiological Effect	Increased Diuresis

US Patents and Regulatory Information for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	206377-001	Feb 24, 2023		DISCN	No	No
Zydus Pharms	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	206377-002	Feb 24, 2023		DISCN	No	No
Accord Hlthcare	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	209281-001	Feb 7, 2019	AB	RX	No	No
Prinston Inc	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	207804-003	Apr 24, 2017	AB	RX	No	No
Torrent	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	206515-003	May 3, 2017		DISCN	No	No
Aurobindo Pharma	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	205391-001	Apr 24, 2017	AB	RX	No	No